THE CHEMISTRY OF DESFERRIOXAMINE CHELATION FOR ALUMINUM OVERLOAD IN RENAL DIALYSIS PATIENTS

被引：11

作者：

DAY, JP ^{[1
]}

ACKRILL, P ^{[1
]}

机构：

[1] UNIV HOSP S MANCHESTER,RENAL UNIT,MANCHESTER M20 8LR,LANCS,ENGLAND

来源：

THERAPEUTIC DRUG MONITORING | 1993年 / 15卷 / 06期

关键词：

ALUMINUM; DESFERRIOXAMINE; RENAL DIALYSIS;

D O I：

10.1097/00007691-199312000-00026

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The iron-chelating agent desferrioxamine now finds extensive use in the treatment and diagnosis of aluminum-related diseases in renal patients. We review the chemistry and pharmacokinetics of desferrioxamine in chelation therapy for patients on hemodialysis.

引用

页码：598 / 601

页数：4

共 28 条

[1] ACKRILL P, 1980, LANCET, V2, P692
[2] ACKRILL P, 1982, P EUR DIAL TRANS, V19, P203
[3] Ackrill P, 1993, Contrib Nephrol, V102, P125
[4] ARAKELIAN S, 1990, J AM SOC NEPHROL, V1, pA322
[5] DEFEROXAMINE THERAPY AND MUCORMYCOSIS IN DIALYSIS PATIENTS - REPORT OF AN INTERNATIONAL REGISTRY
BOELAERT, JR
FENVES, AZ
COBURN, JW
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (06) : 660 - 667
[6] OCULAR AND AUDITORY TOXICITY IN HEMODIALYZED PATIENTS RECEIVING DESFERRIOXAMINE
CASES, A
KELLY, J
SABATER, F
TORRAS, A
GRINO, MC
LOPEZPEDRET, J
REVERT, L
[J]. NEPHRON, 1990, 56 (01): : 19 - 23
[7] DAY JP, 1989, ALUMINIUM AND IRON OVERLOAD IN HAEMODIALYSIS, P42
[8] ALUMINUM ABSORPTION STUDIED BY AL-26 TRACER
DAY, JP
BARKER, J
EVANS, LJA
PERKS, J
SEABRIGHT, PJ
ACKRILL, P
LILLEY, JS
DRUMM, PV
NEWTON, GWA
[J]. LANCET, 1991, 337 (8753) : 1345 - 1345
[9] DAY JP, 1983, CHEM TOXICOLOGY CLIN, P353
[10] DAY JP, 1986, ALUMINUM OTHER TRACE, P184

← 1 2 3 →